A small tweak in the dosing regimen of Eli Lilly’s Alzheimer’s disease drug Kisunla has reduced brain swelling of patients in a trial, the company said Tuesday. In the phase 3 study ...

Below is some more information about taking part in a trial that we are funding with the Alzheimer's Drug Discovery Foundation, looking at whether an existing drug called tadalafil may help to treat a ...

“And they usually get over side effects with time.” Sowa also has concerns about getting the dosing right. “It requires complicated math and conversions,” she says. It depends. Ali ...